Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201102043 Principal Investigator: Vij, Ravi
Title: A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Refractory/Relapsed Multiple Myeloma
Description: The purpose of this research study is to learn about the safety of two anticancer drugs called carfilzomib and pegylated liposomal doxorubicin (PLD) when given together, to see what effects these drugs have on the body and on your disease, and to determine the highest safest dose of carfilzomib that...MORE
___________________________________________________________________________________________________
 Number: 201406067 Principal Investigator: Vij, Ravi
Title: A Phase 1, Dose-Escalation/Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamic Effects of Orally Administered CB-5083 in Patients with Relapsed/Refractory Multiple Myeloma
Description: The purpose of this research study is to determine the most effective dose and side effects of CB-5083 given to patients with multiple myeloma whose disease has not responded to (gotten better with) previous types of treatment or responded at first but then relapsed (progressed or got worse). The st...MORE
___________________________________________________________________________________________________
 Number: 201405035 Principal Investigator: Fehniger, Todd
Title: A Study of ALT-803 in Patients with Relapsed or Refractory Multiple Myeloma
Description: The purpose of this research study is to test different doses of the study drug, ALT-803, to find out which dose of the study drug is safer in people with multiple myeloma. In this study we wish to find what its side effects are and how well it is tolerated. We also wish to find out if the study dru...MORE
___________________________________________________________________________________________________
 Number: 201209068 Principal Investigator: Vij, Ravi
Title: A Phase Ib Study of SAR650984 (Anti-CD38 mAb) in Combination with lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Description: The purpose of this study is to learn more about the investigational drug SAR650984 and when the study drug SAR650984 is given together with the drugs lenalidomide and dexamethasone. We will evaluate the safety and the tolerability of the study drug and we will identify the maximum safe dose of S...MORE
___________________________________________________________________________________________________
 Number: 201101815 Principal Investigator: Vij, Ravi
Title: Connect MM: The Multiple Myeloma disease Registry
Description: This research study is being done to learn more about multiple myeloma and its treatments. Researchers also want to better understand how multiple myeloma impacts the life of people living with multiple myeloma. This is an observational study, which means it is a study that does not prescribe...MORE
___________________________________________________________________________________________________
 Number: 201210094 Principal Investigator: Vij, Ravi
Title: Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (Preamble)
Description: The purpose of this research study is to examine how multiple myeloma is treated by doctors all over the world, how patients respond to these treatments, and the economic impact of these treatments....MORE
___________________________________________________________________________________________________
 Number: 201102270 Principal Investigator: Vij, Ravi
Title: Tissue Acquisition for Analysis of Genetic Progression of Monoclonal Gammopathy of Unknown Significance and Multiple Myeloma
___________________________________________________________________________________________________